The current approach to antimigraine therapy comprises potent serotonin 5-HT 1B/1D
receptor agonists collectively termed triptans. Sumatriptan was the first of these compounds …

Rizatriptan | Drugs Skip to main content SpringerLink Account Menu Find a journal Publish
with us Track your research Search Cart 1.Home 2.Drugs 3.Article Rizatriptan An Update of its …

Objective: To determine the response rate to triptans in alleviating “sinus headache” in
patients with endoscopy‐and computed tomography (CT)‐negative sinus examinations …

We conducted a study to compare the efficacy in migraine headache of nasal sumatriptan
and intravenous ketorolac. The study was a prospective, double-blind study done with a …

Data from seven randomized, placebo-controlled, double-blind phase III clinical trials were
analysed to further evaluate the efficacy of rizatriptan 10 mg (n= 2068) in comparison with …

Migraine is the most common headache complaint in clinical practice. Part 1 of a two-part
series presents a summary of treatments used to reduce the severity and duration of …

Eletriptan is a new selective serotonin agonist approved for the treatment of acute migraine
headaches. To review the pharmacologic, pharmacodynamic, pharmacokinetic, safety, and …

Extracts of Australian plants were screened to detect constituents affecting adenosine di-
phosphate (ADP) induced platelet aggregation and [14C] 5-hydroxytryptamine (5-HT) …

Background: Migraine is a common neurological condition marked by frequent mild to
extreme headaches that last 4 to 72 hours. A migraine headache may cause a pulsing or …

Women aged 25 to 44 years have headaches as their fourth leading cause of physician
visits. 44 Twenty-three million Americans sustain migraine with or without aura. 58 As many …